Sally Woodhead RN COSA-IPOS Joint Scientific Meeting 2012

Abstracts this author is presenting:

• Evaluating pain and analgesic use in patients with solid tumours and bone metastases receiving denosumab or zoledronic acid (ZA) from 3 identically-designed, randomised, double-blind, trials — COSA Posters: Education and Supportive Care